Interstitial Lung Disease Clinical Trials in Aurora, Colorado

4 studies are recruiting for interstitial lung disease in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

   This is a prospective, real world, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) and interstitial lung disease (ILD).

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Colorado - Anschutz Medical Campus, Aurora, Colorado

   Locations

   71 in total

   Run by

   United Therapeutics

   See if you can join NCT06388421 on ClinicalTrials.gov

2. PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

   This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 months to systematically collect clinical, imaging, and biospecimen data. The primary objective is to optimize progressive pulmonary fibrosi…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   University of Colorado | Anschutz Medical Campus, Aurora, Colorado

   Locations

   24 in total

   Run by

   University of Massachusetts, Worcester

   See if you can join NCT06855329 on ClinicalTrials.gov

3. Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

   The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical RA-ILD, in patients with rheumatoid arthritis (RA). The investigators hypothesize that there are common core elements (e.g…

   Stage

   Not phased

   Ages

   45 to 90

   Site

   University of Colorado - Anschutz Medical Campus, Aurora, Colorado

   Run by

   University of Colorado, Denver

   See if you can join NCT03297775 on ClinicalTrials.gov

4. Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

   A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progressi…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   University of Colorado Denver, Aurora, Colorado

   Locations

   4 in total

   Run by

   University of Colorado, Denver

   See if you can join NCT06397677 on ClinicalTrials.gov